START Los Angeles — Los Angeles, California

START Los Angeles is a clinical research site located in Los Angeles, California, United States 90025.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

START Los Angeles has participated in 12 clinical trials with 12 currently active.

Therapeutic areas: PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer.

Sponsors: Whitehawk Therapeutics, Inc., Verastem, Inc., Flare Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

• University of California Los Angeles School of Medicine
• Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
• VA Greater Los Angeles Health System
• Usc/Norris Comprehensive Cancer Center Hospital
• University of Southern California - PT Associates
• University of Southern California Keck School of Medicine/University of Southern California LAC & USC Medical Center
• UCLA Orthodpedic Hospital
• University of Southern California /ID# 164095
• Keck hospital of the University of Southern California
• Los Angeles Orthopedic Hospital, Orthopedic Hemophilia Treatment Center
• University of California Los Angeles - Division of Dermatology
• University California Los Angeles Medical Center (UCLA)

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Los Angeles?

START Los Angeles has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Los Angeles conducted?

START Los Angeles has 12 clinical trials on record, with 12 currently active. Their work covers PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer.

Is START Los Angeles accredited by Crixeo Clinical Trials?

START Los Angeles has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Los Angeles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.